DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a leader in the diagnosis and treatment of cardiac arrhythmias, will be part of a public/private collaboration to fund a global clinical trial to compare catheter ablation to medical therapy in treating atrial fibrillation.
